Abstract Nonketotic hyperglycinemia (NKH) is an inborn error of metabolism caused by deficiency in the glycine cleavage system (GCS); this system consists of four individual constituents, P-, T-, H-, and L-proteins. Several mutations have been identified in P-and T-protein genes, but not in the H-protein gene (GCSH), despite the presence of case reports of H-protein deficiency. To facilitate the mutational and functional analyses of GCSH, we isolated and characterized a human p1-derived artificial chromosome (PAC) clone encoding GCSH. GCSH spanned 13.5 kb and consisted of five exons. Using the PAC clone as a probe, we mapped GCSH to chromosome 16q24 by fluorescence in situ hybridization. The transcription initiation site was determined by the oligonucleotide-cap method, and potential binding sites for several transcriptional factors were found in the 5Ј upstream region. Direct sequencing analysis revealed five single-nucleotide polymorphisms. The expression profiles of P-, T-, and H-protein mRNAs were studied by dot-blot analysis, using total RNA from various human tissues. GCSH was expressed in all 29 tissues examined, while T-protein mRNA was detected in 27 of the 29 tissues. In contrast, the P-protein gene was expressed in a limited number of tissues, such as liver, kidney, brain, pituitary gland, and thyroid gland, suggesting distinct transcriptional regulation of each GCS constituent.
Introduction
Nonketotic hyperglycinemia (NKH) is an inborn error of metabolism characterized by the accumulation of glycine in body fluids (Tada et al. 1969) . In patients with NKH, severe neurological symptoms, such as convulsive seizures, coma, and respiratory distress, develop within a few days after birth (Almosh et al. 1995) . The fundamental defect lies in the glycine cleavage system (GCS; EC 2.1.2.10). The GCS, a multi-enzyme complex that exists in mitochondria (Motokawa and Kikuchi 1972; Kikuchi 1973) , consists of four constituents; P-protein [EC 1.4.4 .2], T-protein [EC, 2.1.2.10], H-protein, and L-protein [EC2.1.8.1.4]. P-protein and T-protein are also called glycine decarboxylase (GLDC) and aminomethyltransferase (AMT), respectively. H-protein is referred to as a hydrogen carrier protein that transfers the aminomethyl moiety, which is generated by the decarboxylation of glycine, to T-protein for further degradation. L-protein is dihydrolipoamide dehydrogenase, a housekeeping enzyme that serves as a component of other complex enzyme systems, such as the pyruvate dehydrogenase complex.
Enzymatic analysis has identified three metabolic lesions in NKH, deficiencies of P-, T-, and H-proteins (Almosh et al. 1995) . The first mutation identified in NKH was in the P-protein gene (Kure et al. 1991b) . Subsequently, some patients were found to have mutations in the T-protein gene (Nanao et al. 1994a; Kure et al. 1998; Toone et al. 2001) . However, mutations in the Hprotein gene have not been identified, despite reports of a patient who was enzymatically deficient in H-protein (Trauner et al. 1981; Hiraga et al. 1981) . Although the genomic organization of the human H-protein gene (GCSH) has been partially described (Koyata and Hiraga 1991b) , complete and accurate information is still missing, especially regarding the sequence information for each exon/ intron boundary that is required for single-exon amplification. Furthermore, the chromosomal localization and the transcription initiation site of the GCSH gene remain unknown.
Here we report the structure and chromosomal localization of the H-protein gene. We isolated a p1-derived artificial chromosome (PAC) clone encoding GCSH and determined the chromosomal localization by fluorescence in situ hybridization (FISH) analysis. We then established a system of single-exon amplification, using flanking intronic primers, and identified several single-nucleotide polymorphisms (SNP). The transcription initiation site and the expression profile of three GCS components were also studied. Our results should facilitate the studies of NKH caused by H-protein deficiency.
Materials and methods

Isolation and characterization of PAC clone encoding GCSH
A human PAC genomic library was screened by polymerase chain reaction (PCR), using hH1 and hH2 primers, which amplified the entire region of intron 4 ( Table 1) . The hH1 and hH2 primers were designed based on the GeneBank sequence data (accession numbers, S50220 and S50222). One PAC clone (PACHH1) was isolated and subjected to structural analysis. Exon-intron boundary sequences were determined by a cycle sequencing method, using 1 µg of PAC genomic DNA and 1 µl of thermostable topoisomerase (ThermoFidelase I; Fidelity Systems, Gaithersburg, MD, USA) according to the manufacturer's protocol (http://www.fidelitysystems.com/TF1.html). The lengths of introns 1-4 were estimated by long-distance PCR amplification, with the primer sets, HHE1F/HHE2R, HHE2F/HHE3R, HHE3F/HHE4R, and HHE4F/HHE5R, respectively (Table 1) . One microgram of the purified genomic PACHH-1 DNA and an LA PCR kit (Takara, Tokyo, Japan) were used for the PCR.
Chromosomal mapping DNA purified from the PACHH-1 clone was labeled with digoxigenin-labeled dUTP by nick translation. The labeled probe was combined with sheared human DNA and hybridized to normal metaphase chromosomes derived from phytohemagglutinine-stimulated peripheral blood lymphocytes, in a solution containing 50% formamide, 10% dextran sulfate, and 2ϫ standard sodium citrate (SSC). Specific hybridization signals were detected by incubating the hybridized slides in fluorescein-labeled antidigoxigenin antibodies, followed by counterstaining with DAPI (4, 6-diamidino-2-phenylindole). A total of 80 metaphase cells were analyzed for mapping. To confirm the chromosomal assignment, a DNA fragment that was previously mapped to chromosome 16p13 was hybridized together with PACHH-1.
Analysis of the transcription initiation site
The H-protein cDNA fragment containing the transcription start site was obtained by an oligonucleotide-cap method, using a Cap Site PCR kit (Nippon Gene, Toyama, Japan) (Maruyama and Sugano 1994) . An H-protein cDNA fragment containing the cap site was amplified by nested PCR. The cDNA fragment containing the cap site was designed to have the 25-mer oligonucleotide linker, 5Ј-CAAGGTACG CCACAGCGTATGATGC-3Ј. H-protein cap site cDNA was then amplified with the forward primers that were complementary to the linker and H-protein-specific reverse primers. The first PCR was performed with hH6 and hH4 primers, while the second PCR used hH3 and hH5 primers ( Table 1 ). The products of the second PCR were separated by 4% agarose gel electrophoresis. Gel bands were excised and purified with a QIAEX II Gel Purification kit (Qiagen, Hilden, Germany). Nucleotide sequences of the PCR products were determined with a dye-terminator sequencing kit and an ABI 310 DNA sequencer (PE Biosystems, Forester, MA, USA).
Screening for SNPs
Genomic DNA samples were purified from 20 Caucasian and 20 Japanese control subjects for the screening of SNPs. DNA fragments containing exons 1-5 were amplified by PCR with the primer sets HHE1F/HHE1R, HHE2F/ HHE2R, HHE3F/HHE3R, HHE4F/HHE4R, and HHE5F/ HHE5R, respectively (Table 1) . Each amplicon was purified as described above and used as a sequencing template. Sequencing was performed with the ABI 310 DNA sequencer and M13 and reverse dye-primer sequencing kits, according to the manufacturer's protocol (PE Biosystems).
RNA dot blot analysis
A nylon membrane on which the total RNA of 29 various human tissues was blotted (Clontech, Palo Alto, CA, USA) was probed with 32 P-labeled cDNA fragments (~500 bp) encoding human H-, P-, and T-protein cDNA, as described previously (Kure et al. 1991a ). Hybridization and washing were performed according to the manufacturer's protocol. The radioactivity of each dot spot was measured with Molecular Imager FX (Bio-Rad, Hercules, CA, USA). Background radioactivity was estimated by measuring the radioactivity of a 100-ng Escherichia coli DNA spot and subtracting this value from the measured radioactivity of each spot. To measure the relative levels of the P-, T-, and H-protein mRNAs in each organ, we arbitrarily designated the radioactivity of the liver RNA spot as 1.0, and estimated the relative abundance of each mRNA by calculating the radioactivity of each RNA spot as a percentage of that of the liver RNA spot.
Results
Structure of GCSH
One positive PAC clone, PACHH-1, was isolated by PCR screening with the GCSH-specific primers. The sequences of the exon/intron boundaries and the size of each intron are shown in Fig. 1 . All exon/intron boundaries adhered to the canonical gt/ag rule. The H-protein gene spans 13.5 kb and consists of five exons. Exon 1 corresponds to the 5Ј-untranslated region and the initiator AUG codon. A lipoic acid binding the Lys 107 residue is located in exon 4 (Fujiwara et al. 1986 ). The translation termination codon is encoded in exon 5, which is followed by a 3Ј-untranslated sequence of 542 bp. The transcription start site was then determined by the oligo nucleotide-cap method. A 143-bp fragment was generated by the nested PCR amplification, and contained a sequence from nucleotides 215 to 340 in Fig. 1 . The transcription, therefore, appeared to be initiated at an adenine nucleotide 215, 169 bp upstream from the translation initiation ATG triplet. Neither a typical TATA box sequence nor its homologue was found in the 5Ј-flanking region, but two CCAAT boxes were present, at nucleotides 30-34 and 182-186 (Fig. 1) . A potential binding site for Sp1 was present at nucleotides 7-12. The flanking region also contained DNA motifs for AP2 at nucleotides 2-28, 39-46, and 147-154.
Chromosomal mapping of GCSH Subchromosomal position was determined by FISH analysis with the fluorescence-labeled PACHH-1 DNA. The initial experiment resulted in specific labeling of the long arm of chromosome 16, on the basis of size, morphology, and banding pattern (arrow "a" in Fig. 2 ). The specific labeling was observed in 76 of 80 metaphase cells. To confirm the location, we hybridized the PACHH-1 probe together with a human PAC genomic clone that had previously been mapped to chromosome 16p13 (arrow "b" in Fig. 2 ). Observation of the specifically labeled chromosome 16 demonstrated that the clone PACHH-1 was located at the terminus of the long arm of chromosome 16, an area that corresponds to band 16q24.
SNPs in GCSH
Twenty Caucasian and 20 Japanese control subjects were screened for SNPs by direct sequencing analysis of singleexon amplicons. We identified five SNPs, one in exon 1 and four in introns 1, 2, and 4 ( Table 2 ). The exonic polymorphism, a T-to-C substitution in codon 21 (TTA to TCC), caused an amino acid change from leucine (L) to serine (S), which was located in the mitochondrial leader peptide of the H-protein. The S21 allele frequencies in the Caucasian and Japanese control subjects were 22.5% and 17.5%, respectively. The other four SNPs were located in introns and caused no amino-acid substitutions. The intronic SNPs were observed in both Caucasian and Japanese controls. The IVS2ϩ54tϾc polymorphism was found only in Japanese, while the other three polymorphisms, IVS1Ϫ20aϾc, IVS2Ϫ84gϾa, and IVS4Ϫ62tϾa, were identified only in Caucasians ( Table 2) .
Expression of P-, T-, and H-protein mRNAs in various tissues
The relative amounts of H-, P-, and T-protein mRNAs in each tissue were calculated, and findings are summarized in Fig. 3 . H-protein mRNA was detected in all 29 tissues examined. T-protein mRNA was expressed in all tissues, except for stomach and bone marrow. P-protein mRNA was detected in a limited number of tissues: strong gene expression was detected in liver, placenta, and kidney; moderate expression in brain, small intestine, thyroid gland, and pituitary gland; and weak expression in colon, bladder, and lung. No P-protein mRNA signals were detected in other tissues.
Discussion
We isolated a PAC clone (PACHH-1) encoding the human H-protein gene (GCSH) and mapped GCSH on chromosome 16q24 by FISH analysis. Previous genetic analysis of the GCS revealed that the human P-protein gene (GLDC) consisted of 25 exons (Takayanagi et al. 2000) and was mapped to chromosome 9p22-24 (Isobe et al. 1994 ). The Tprotein gene (AMT) was shown to consist of 9 exons and was located on 3p21.1-2 (Nanao et al. 1994b ). The L-protein gene (GCSL) was shown to have 12 exons (Feigenbaum and Robinson 1993) and resided on chromosome 7q31-32 (Scherer et al. 1991) . We recently reported a processed pseudogene of GLDC, designated ψGLDC, which showed 97.5% homology with the GLDC cDNA (Takayanagi et al. 2000) . Neither the T-protein gene nor the L-protein gene has any known pseudogenes. When GeneBank was screened for homologous sequences with human H-protein cDNA, three highly homologous processed type pseudogenes were found. Their chromosomal location, accession numbers, and sequence identities are: chromosome 1q22-23.3, HS702J19, 99.6%; chromosome 5p, AC011401, 96.7%; chromosome 7p, AC007551, 90.0%; and chromosome 19, AC008976, 98.9%. If a unit evolutionary period (UEP-time need for a 1% divergence) of 2-3.5 million years is accepted for a silent site, then these processed pseudogenes probably arose 0.8-35 million years ago (Gonzales et al. 1993) .
We determined the structural organization of GCSH and found that its transcription start site was 168 bp upstream from the translation initiation triplet, using the oligo nucleotide-cap method. Koyata and Hiraga (1991b) previously assigned the transcription initiation site to 168 bp upstream of the initiation triplet, by primer extension analysis, essentially agreeing with our result. Their S1 nuclease protection analysis, however, yielded no specific band. They concluded that there was an additional noncoding exon located 5Ј upstream of exon 1. Because the cap site fragment in our experiment did not contain any foreign sequence and its length agreed with the results of their primer extension analysis, we cannot explain the discrepancy. The mitochondrial leader peptide of the H-protein precursor consists of 48 amino acids, and the L21S polymorphism was located in the middle of this sequence . Interestingly, all of the processed pseudogenes of GCSH described above have the S21 allele, suggesting that the L21 allele arose later than the S21 allele. The L21S polymorphism may affect the efficiency of mitochondrial import of H-protein, causing individual variation in GCS activity and in glycine levels in serum and cerebrospinal fluid. Further functional analysis is required to elucidate the physiological significance of this polymorphism. RNA dot-blot analysis with P-, T-, and H-protein cDNA probes revealed that the genes encoding the P-, T-, and Hproteins were not coordinately expressed. The H-protein gene was expressed in all tissues examined, suggesting that it was a housekeeping gene. The result was in line with our observation that GCSH had no typical TATA box, because absence of the TATA box is commonly observed in housekeeping genes. In contrast, the P-protein gene was expressed in a limited number of tissues. Enzymatic activity of the GCS was identified only in liver, brain, and kidney, in which tissues P-protein mRNA was abundantly expressed (Yoshida and Kikuchi 1973) . A similar relationship has also been observed in other species, such as chickens (Kure et al. 1991a ) and bovine (Okamura-Ikeda et al. 1991) . Therefore, the limited expression of the P-protein gene appears to determine distribution of the functional GCS. In this context, it is interesting to note that moderate expression of the P-protein gene, together with H-protein and T-protein gene expression, was observed in the pituitary and thyroid glands. To date, GCS activity in these endocrine organs remains uninvestigated. It would be intriguing to examine whether the GCS plays an important role in the regulation of endocrine systems in the pituitary and thyroid glands.
Enzymatic analysis suggested that most patients with neonatal onset NKH had deficient P-protein or T-protein activity (Tada and Hayasaka 1987) . A common GLDC mutation, S564I, was identified in Finland, where the incidence of neonatal onset NKH is unusually high (Kure et al. 1992) . Nanao et al. (1994a) reported three AMT mutations in two patients, with neonatal and infantile onset NKH. A missense AMT mutation was also identified in a large Israeli-Arab family with neonatal onset NKH (Kure et al. 1998) . Toone et al. (2000 and 2001) reported several AMT mutations, including a recurrent mutation, in Caucasian patients. H-protein deficiency seems to be relatively rare, compared with P-and T-protein deficiencies. Trauner et al. (1981) reported a patient with atypical NKH who was asymptomatic in the neonatal period and did not show the typical convulsive seizures, but who later showed mental retardation. This patient was proven to have deficient Hprotein activity, although P-and T-protein activities were normal; almost all of the H-protein was in the apo-enzyme form (Hiraga et al. 1981) . Our results showing the structure, polymorphism, and expression of GCSH should facilitate the molecular analysis of such patients with variant forms of NKH that are caused by H-protein deficiency.
